MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
1.380
+0.110 (8.66%)
At close: Aug 13, 2025, 4:00 PM
1.500
+0.120 (8.70%)
Pre-market: Aug 14, 2025, 9:17 AM EDT
MaxCyte Market Cap
MaxCyte has a market cap or net worth of $147.12 million as of August 14, 2025. Its market cap has decreased by -70.70% in one year.
Market Cap
147.12M
Enterprise Value
39.06M
1-Year Change
-70.70%
Ranking
Category
Stock Price
$1.38
Market Cap Chart
Since the IPO on March 10, 2021, MaxCyte's market cap has decreased from $494.67M to $147.12M, a decrease of -70.26%. That is a compound annual growth rate of -23.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 135.39M | -69.21% |
| Dec 31, 2024 | 439.69M | -9.93% |
| Dec 29, 2023 | 488.14M | -12.55% |
| Dec 30, 2022 | 558.17M | -45.87% |
| Dec 31, 2021 | 1.03B | 108.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |